Cheryl Key

Cheryl Key serves as the Director of Drug Safety at Bicycle Therapeutics since April 2023, following a career break from July 2022 to April 2023. Prior to their current role, Cheryl held key positions in various organizations, including Head of Safety Evaluation and Head of Drug Safety at Mundipharma from March 2020 to June 2022, and Medical Group Lead/Principal PV Medic at ProductLife Group from April 2018 to March 2020. Cheryl's extensive experience includes significant roles at NDA Group AB, Amgen, and Quintiles, where responsibilities ranged from managing safety evaluations to advising on regulatory strategies and pharmacovigilance. In addition to professional roles, Cheryl contributed to the Faculty of Pharmaceutical Medicine as a member of the Board of Trustees and the Trainees Subcommittee. Cheryl holds an MBBS degree in Medicine from Charing Cross and Westminster Medical School, obtained from 1986 to 1991.